Clinical characteristics and risk factors of acute lymphoblastic leukemia in children with severe infection during maintenance treatment

被引:1
|
作者
Yin, Tiantian [1 ]
Han, Juan [1 ]
Hao, Jinjin [1 ]
Yu, Hui [1 ]
Qiu, Yining [1 ]
Xu, Jiawei [1 ]
Peng, Yun [1 ]
Wu, Xiaoyan [1 ]
Jin, Runming [1 ]
Zhou, Fen [1 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Pediat, Wuhan 430022, Peoples R China
来源
CANCER MEDICINE | 2023年 / 12卷 / 19期
关键词
acute lymphoblastic leukemia; children; maintenance phase; risk factors; severe infection; GRANULOCYTE TRANSFUSIONS; PEDIATRIC-PATIENTS; INDUCTION THERAPY; CANCER; PNEUMONIA; COMPLICATIONS;
D O I
10.1002/cam4.6495
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Infection is the most common adverse event of acute lymphoblastic leukemia (ALL) treatment and is also one of the main causes of death.Methods: To investigate the clinical characteristics and risk factors of severe infections during the maintenance phase of ALL treatment, we conducted a retrospective study.Results: A total of 181 children were eligible and 46 patients (25.4%) suffered from 51 events of severe infection, most of which occurred in the first half year of the maintenance phase (52.9%). The most common infection was pulmonary infection (86.3%) followed by bloodstream infection (19.6%). The main symptoms of ALL patients with pulmonary infection were fever, cough, and shortness of breath. The main manifestations of computer tomography (CT) were ground glass shadow (56.8%), consolidation shadow (27.3%), and streak shadow (25%). Multivariate binary logistic regression analysis showed that agranulocytosis, agranulocytosis >= 7 days, anemia, and low globulin level were independent risk factors for severe infection during the maintenance phase (all p < 0.05).Conclusions: Taken together, blood routine examinations and protein levels should be monitored regularly for ALL patients in the maintenance phase, especially in the first 6 months. For ALL patients with risk factors, preventive anti-infective or supportive therapies can be given as appropriate to reduce the occurrence of severe infections.
引用
收藏
页码:19372 / 19382
页数:11
相关论文
共 50 条
  • [41] Evaluation of inherited prothrombotic risk factors in children with acute lymphoblastic leukemia
    Te, Valerie Li Thiao
    Favier, Remi
    Borg, Jeanne-Yvonne
    Cadet, Estelle
    Reynaud, Jacqueline
    Micheli, Julie
    Rachieru, Petronela
    Berger, Claire
    Auvrignom, Anne
    Schneider, Pascale
    Leverer, Guv
    Muchemble, Briitte Pautari
    BLOOD, 2007, 110 (11) : 56B - 56B
  • [42] Thrombosis Risk Factors Assessment In Children Treated For Acute Lymphoblastic Leukemia
    Smalisz-Skrzypczyk, Katarzyna
    Klukowska, Anna
    Pawelec, Katarzyna
    Matysiak, Michal
    BLOOD, 2013, 122 (21)
  • [43] Risk factors for oral lesions in children with acute leukemia lymphoblastic in chemotherapy
    Castellanos-Toledo, Araceli
    Idania Gutierrez-Vargas, Rosaura
    Portilla-Robertson, Javier
    Igor Lopez-Carrera, Yuri
    de Jesus Ascencio-Montiel, Ivan
    Martinez-Avalos, Armando
    GACETA MEXICANA DE ONCOLOGIA, 2014, 13 (02): : 97 - 105
  • [44] PREDICTABLE RISK-FACTORS IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    SAKURAI, M
    KAMIYA, H
    KAWAI, K
    KAWASAKI, H
    KOMADA, Y
    IDO, M
    OCHIAI, H
    AKANE, H
    SATO, K
    MEDICAL AND PEDIATRIC ONCOLOGY, 1986, 14 (03): : 140 - 143
  • [45] Cryptosporidiosis in Children With Acute Lymphoblastic Leukemia on Maintenance Chemotherapy
    Domenech, Carine
    Rabodonirina, Meja
    Bleyzac, Nathalie
    Pages, Marie-Pierre
    Bertrand, Yves
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2011, 33 (07) : 570 - 572
  • [46] Norovirus Infection in Children with Acute Lymphoblastic Leukemia
    Reddy, Nalla Anuraag
    Raj, Keerthi
    Lashkari, Harsha Prasada
    INFECTION AND CHEMOTHERAPY, 2023, 55 (03): : 403 - 407
  • [47] Risk Factors of Neutropenic Enteropathy During Induction Phase of Treatment of Childhood Acute Lymphoblastic Leukemia
    Karim, M. A.
    Jahan, Y.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S157 - S157
  • [48] Risk Factors for Infection-Related Outcomes During Induction Therapy for Childhood Acute Lymphoblastic Leukemia
    Afzal, Samina
    Ethier, Marie-Chantal
    Dupuis, L. Lee
    Tang, Laureen
    Punnett, Angela S.
    Richardson, Susan E.
    Allen, Upton
    Abla, Oussama
    Sung, Lillian
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2009, 28 (12) : 1064 - 1068
  • [49] Pneumocystis carinii pneumonia during maintenance treatment of childhood acute lymphoblastic leukemia
    Poulsen, A
    Demeny, AK
    Plum, CB
    Nielsen, KG
    Schmiegelow, K
    MEDICAL AND PEDIATRIC ONCOLOGY, 2001, 37 (01): : 20 - 23
  • [50] The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment
    Rudin, Shoshana
    Marable, Marcus
    Huang, R. Stephanie
    GENOMICS PROTEOMICS & BIOINFORMATICS, 2017, 15 (02) : 82 - 93